Research Landscape
Improving care through evidence and innovation.
What we know:
BEST-2: Azithromycin vs. Co-amoxiclav
Macrolides: Reduce exacerbation frequency
ERS Guidelines: Standard for global care
Key Research Priorities:
P. aeruginosa management
Optimal mucolytic therapy
Earlier diagnosis and standardised imaging
Reducing regional disparities
